Get Involved
On the day

Innovation in Clinical Trials

21 November 2018

It takes 10 years and $1-2 billion to get a new pharmaceutical product to market. Success rates for drugs making it to market are as low as 5-10%, depending on disease area.

This track will feature an overview of the pharmaceutical R&D process focusing on clinical trials and the reasons why it takes so long and why so few drugs get to market. We will examine what innovators are doing to make the R&D process more efficient and more successful.

After the discussion there will be a connecting session for pharma and innovators to meet and discuss potential partnerships.  

     

Buy Tickets

Leader

 

Jason Foster, Managing Director, Health Equity Consulting
Jason is Managing Director of Health Equity Consulting, a Non-Executive Director of GripAble & Auxita, a principal in an early stage HealthTech investment vehicle, a Venture Partner at Deep Science Ventures and Co-Chair of the Tech London Advocates HealthTech group.

 

 

Buy Tickets

Speakers

09:15 Jason Foster
TLA and Health Equity Consulting
Marco Mohwinkel
CCO, Compass Pathways
Download

Download presentation

Introduction: Welcome from the Co-Chairs

09:45

Linda Pointon
Research Project Manager, University of Cambridge
with Marco Mohwinkel

Download

Download presentation		 Overview of the Clinical Trial Process: Why is it so Hard to Bring Products to Market?
09:45 Moderator:
Marco Mohwinkel
CCO, Compass Pathways
Zeshan Gory
VP Strategy, Antidote
Murat Tunaboylu
Director, Antiverse
Maya Zlatanova
CEO, FindMeCure
Luca Emili
CEO, InSilico Trials
Dr Peter Fish
Head of Clinical Partnerships, Mendelian
Julie Walters
Founder, Raremark
Bruce Hellman
CEO, Umotif

Download

Download presentation






Download

Download presentation

Download

Download presentation

Innovator Panel: What are Innovators Doing to Make Clinical Trials More Efficient and to Increase the Likelihood of Success

10:30 Moderator: Jason Foster
Co-Chair Tech London Advocates HealthTech Group 		Innovator Panel: Q&A Session
11:00 NETWORKING BREAK
11:30

Case Study Presentations: Real World Use of Innovation in Clinical Trials
Dr Peter Fish
Head of Clinical Partnerships, Mendelian
Dr Jagtar Singh Nijar
NIHR Clinical Lecturer in Rheumatology
Luca Emili
CEO, InSilico Trials
Maya Zlatanova
CEO, FindMeCure
Murat Tunaboylu
Director/Bioinformatician, Antiverse








Download

Download presentation


Rare Disease Patient


Working with the FDA on Simulation

Patient Clinical Trial Connection

AI in Pre-Clinical Drug Discovery

12:30 TLA Clinical Trial Connector Session: Bringing Innovators and Corporates Together
13:00 End of Track